Cramer's High-Growth Pharma With Money Flow
497 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by barrons3
DESCRIPTION:

Date updated:03-12-2009

"To me it looks like we have a nice combination of beaten-down stocks, good growth and money that is at last freed up to invest, dedicated money that stays with the remainder of the group no matter what." - Jim Cramer

symbol name last price % change open
  • +
  • DNA
    N/a
  • $80.43
  • 0.00
  • $80.43

Look at that money flowing out of Genentech (DNA) and into the other high-growth health care companies.

People owning DNA also tend to own: AAPLDSCMGOOGXOMDWELXGLW

TheStreet.com Rating: No Rating What is this?

  • +
  • CELG
    Celgene Corporati
  • $54.97
  • -1.40%
  • $53.81

Look at the money flowing into Celgene (CELG) or into Abbott (ABT) and into Amgen (AMGN) and Biogen (BIIB).

People owning CELG also tend to own: GTIACIRADSTXNVARASHBNI

TheStreet.com Rating: B- What is this?

  • +
  • ABT
    Abbott Laboratori
  • $54.08
  • -0.61%
  • $53.49

Look at the money flowing into Celgene (CELG) or into Abbott (ABT) and into Amgen (AMGN) and Biogen (BIIB).

People owning ABT also tend to own: AGNBMYBRLCEPHENDPFRXHSP

TheStreet.com Rating: A- What is this?

  • +
  • AMGN
    Amgen Inc.
  • $56.50
  • -1.02%
  • $55.98

Look at the money flowing into Celgene (CELG) or into Abbott (ABT) and into Amgen (AMGN) and Biogen (BIIB).

People owning AMGN also tend to own: AAPLGESGPCECEMRVLOMRIANF

TheStreet.com Rating: B What is this?

  • +
  • BIIB
    Biogen Idec Inc
  • $46.92
  • -1.12%
  • $46.20

Look at the money flowing into Celgene (CELG) or into Abbott (ABT) and into Amgen (AMGN) and Biogen (BIIB).

People owning BIIB also tend to own: APOLBRK-BDELLELOSLXKSAFMSGTL

TheStreet.com Rating: B- What is this?

  • +
  • GILD
    Gilead Sciences
  • $46.56
  • -0.89%
  • $46.00

Even Gilead (GILD) is barely down despite the CV Therapeutics (CVTX) deal. This is $193 billion in health care deals in the last few weeks! That's a lot of cash to come back in!

People owning GILD also tend to own: ACASAINVARCCAUBACCELFCX

TheStreet.com Rating: B What is this?

  • +
  • CVTX
    Cvtx
  • $0.00
  • N/A
  • $N/A

Even Gilead (GILD) is barely down despite the CV Therapeutics (CVTX) deal. This is $193 billion in health care deals in the last few weeks! That's a lot of cash to come back in!

People owning CVTX also tend to own: AGIXAVIDCTLMDSTIGLWINTVIVGN

TheStreet.com Rating: No Rating What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 30, 2009 With Black Friday behind us and another data-heavy week ahead, it’s time to turn once again to Rocket Stocks, our list of b...

11.30.09 | 09:16 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 27, 2009 According to Jim Cramer, investors need to know the four enemies of all bull markets. On Wednesday’s “Mad Money” TV show...

11.27.09 | 13:36 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 27, 2009 According to CNBC’s “Fast Money” traders, the adjustment in the third-quarter GDP figure released on Tuesday from an exp...

11.27.09 | 12:22 PM
Black Friday Short-Squeeze Oppor...

By Jonas Elmerraji Posted on Nov. 25, 2009 With Thanksgiving fast approaching, retailers have one thing on their collective minds: Black Friday. After all, the day, whi...

11.25.09 | 13:33 PM
more articles
The YouTube Exchange
07.22.09 | 17:45 PM From author Rawbrrt
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
Forex Basics
11.30.09 | 10:55 AM From author cputech
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
more forums
today 's lists
Cramer's Lightning Round

These are the stocks from Jim Cramer's Nov. 24 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more

Analyst Upgrades

Analyst Upgrades or Estimate Increases for Nov. 30, 2009. Read more here. more

Earnings Announcements

Here is a list of some of the companies that will report earnings on Tuesday (Dec. 1, 2009). For some of the companies below, EPS estimates* are provided. * Analyst o... more